Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 1, 1997Journal of Biological ChemistryOpen Access

Khafrefungin, a Novel Inhibitor of Sphingolipid Synthesis

View Full Paper
Ask AI
Bookmark
Share

Authors

SMSuzanne MandalaMerck & Co., Inc., Rahway, NJ, USA (United States)RTRosemary ThorntonMerck & Co., Inc., Rahway, NJ, USA (United States)MRMark RosenbachMassanutten Regional Library

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mandala et al. (1997) studied this question.

synapsesocial.com/papers/6a832622a250d11ff44cd9f1https://doi.org/10.1074/jbc.272.51.32709
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Elevated recombination rates in transcriptionally active DNA1989 · 1,659 citations
  2. 2Aureobasidins, new antifungal antibiotics. Taxonomy, fermentation, isolation, and properties.1991 · 150 citations
  3. 3Sphingolipids—The Enigmatic Lipid Class: Biochemistry, Physiology, and Pathophysiology1997 · 648 citations
  4. 4Sphingolipid Synthesis as a Target for Antifungal Drugs1997 · 398 citations
  5. 5The Discovery of Australifungin, a Novel Inhibitor of Sphinganine N-Acyltransferase from Sporormiella australis. Producing Organism, Fermentation, Isolation, and Biological Activity.1995 · 189 citations